NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

GNI Group Ltd (OTCGREY: GNIIF)

 
GNIIF Technical Analysis
5
As on 1st Jan 2026 GNIIF STOCK Price closed @ 15.50 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.13 & Strong Sell for SHORT-TERM with Stoploss of 0.57 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

GNIIFSTOCK Price

Open 15.50 Change Price %
High 15.50 1 Day -0.45 -2.82
Low 15.50 1 Week -0.45 -2.82
Close 15.50 1 Month -0.45 -2.82
Volume 100 1 Year -0.45 -2.82
52 Week High 15.95 | 52 Week Low 15.50
 
OTCGREY USA Most Active Stocks
XANAF 0.04 -33.33%
IARED 24.62 %
CVMCA 22.54 -0.75%
JRVMF 0.01 0.00%
GCEA 29.00 -21.20%
AHLD 82.75 -2.93%
MAXC 1.78 0.00%
KAKZF 110.12 4.72%
MNSLV 25.50 1.03%
ABSOF 0.03 -62.50%
 
OTCGREY USA Top Gainers Stocks
HBPCF 1.73 981.25%
CBVTF 0.09 800.00%
KBSR 1.09 445.00%
BLBRF 0.04 300.00%
TCPFF 0.12 250.00%
TCPFF 0.12 250.00%
FTROF 1.11 221.43%
FTROF 1.11 221.43%
WDGJY 6.76 203.03%
WDGJY 6.76 203.03%
 
OTCGREY USA Top Losers Stocks
MGPRF 0.00 -100.00%
TBMIF 0.00 -100.00%
CVVRF 0.00 -100.00%
BWNAF 0.00 -100.00%
EKSN 0.00 -100.00%
VANTF 0.00 -100.00%
DWWEF 0.00 -100.00%
PTHIF 0.07 -90.91%
PTHIF 0.07 -90.91%
SIUDF 0.08 -87.50%
 
 
GNIIF
Daily Charts
GNIIF
Intraday Charts
Whats New @
Bazaartrend
GNIIF
Free Analysis
 
GNIIF Important Levels Intraday
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
RESISTANCE15.50
 
GNIIF Forecast March 2026
4th UP Forecast16.37
3rd UP Forecast16.09
2nd UP Forecast15.92
1st UP Forecast15.75
1st DOWN Forecast15.25
2nd DOWN Forecast15.08
3rd DOWN Forecast14.91
4th DOWN Forecast14.63
 
GNIIF Weekly Forecast
4th UP Forecast16.37
3rd UP Forecast16.09
2nd UP Forecast15.92
1st UP Forecast15.75
1st DOWN Forecast15.25
2nd DOWN Forecast15.08
3rd DOWN Forecast14.91
4th DOWN Forecast14.63
 
GNIIF Forecast2026
4th UP Forecast16.37
3rd UP Forecast16.09
2nd UP Forecast15.92
1st UP Forecast15.75
1st DOWN Forecast15.25
2nd DOWN Forecast15.08
3rd DOWN Forecast14.91
4th DOWN Forecast14.63
 
 
GNIIF Other Details
Segment EQ
Market Capital 130171280.00
Sector Other
Industry Other
Offical website >
 
GNIIF Address
GNIIF
 
GNIIF Latest News
 
Your Comments and Response on GNI Group Ltd
 
GNIIF Business Profile
GNI Group Ltd. researches, develops, manufactures, and sells pharmaceutical drugs and traditional Chinese medicines in Japan and internationally. The company provides Etuary for the treatment of idiopathic pulmonary fibrosis. It is also developing Etuary for the treatment of radiation pneumonitis, which is in pilot study for Phase III clinical trials; Tamibarotene, a product for treating acute promyelocytic leukemia; and F351 that is in Phase II clinical trial for the treatment of liver fibrosis. In addition, the company is developing Etuary for the treatment of diabetic nephropathy and connective tissue disease associated interstitial lung disease; and F573 for acute liver failure and acute-on-chronic liver failure. Further, it is developing diabetic nephropathy; and connective tissue disease associated interstitial lung disease, which are in investigational new drug application stage. GNI Group Ltd. was founded in 2001 and is headquartered in Tokyo, Japan. Address: Nihonbashi-Honcho YS Building, Tokyo, Japan, 103-0023
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service